Morgan Stanley’s Aratana Therapeutics, Inc. PETX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-82,569
Closed -$426K 6940
2019
Q2
$426K Buy
82,569
+35,977
+77% +$186K ﹤0.01% 4691
2019
Q1
$168K Sell
46,592
-257,353
-85% -$928K ﹤0.01% 5154
2018
Q4
$1.86M Sell
303,945
-160,926
-35% -$986K ﹤0.01% 3833
2018
Q3
$2.72M Sell
464,871
-31,462
-6% -$184K ﹤0.01% 3751
2018
Q2
$2.11M Buy
496,333
+97,847
+25% +$416K ﹤0.01% 4034
2018
Q1
$1.76M Sell
398,486
-29,660
-7% -$131K ﹤0.01% 4122
2017
Q4
$2.25M Buy
428,146
+339,502
+383% +$1.78M ﹤0.01% 3935
2017
Q3
$543K Buy
88,644
+2,054
+2% +$12.6K ﹤0.01% 4830
2017
Q2
$626K Buy
86,590
+37,570
+77% +$272K ﹤0.01% 4659
2017
Q1
$260K Sell
49,020
-58,301
-54% -$309K ﹤0.01% 5185
2016
Q4
$771K Buy
107,321
+26,079
+32% +$187K ﹤0.01% 4655
2016
Q3
$760K Buy
81,242
+74,399
+1,087% +$696K ﹤0.01% 4245
2016
Q2
$43K Buy
6,843
+577
+9% +$3.63K ﹤0.01% 5574
2016
Q1
$35K Buy
6,266
+3,193
+104% +$17.8K ﹤0.01% 5745
2015
Q4
$17K Buy
3,073
+204
+7% +$1.13K ﹤0.01% 6092
2015
Q3
$24K Sell
2,869
-166,026
-98% -$1.39M ﹤0.01% 5994
2015
Q2
$2.55M Sell
168,895
-59,038
-26% -$893K ﹤0.01% 3399
2015
Q1
$3.65M Buy
227,933
+100,008
+78% +$1.6M ﹤0.01% 3045
2014
Q4
$2.28M Buy
127,925
+109,862
+608% +$1.96M ﹤0.01% 3462
2014
Q3
$181K Buy
18,063
+9,367
+108% +$93.9K ﹤0.01% 5195
2014
Q2
$136K Buy
8,696
+6,277
+259% +$98.2K ﹤0.01% 5350
2014
Q1
$45K Buy
2,419
+1,931
+396% +$35.9K ﹤0.01% 5754
2013
Q4
$9K Buy
+488
New +$9K ﹤0.01% 6065